Journal ArticleOPEN ACCESS

Is Systemic Inflammatory Response Index (SIRI) a Reliable Tool for Prognosis of Gastric Cancer Patients Without Neoadjuvant Therapy?

  • Yazici H
  • Yegen S
Cureus (2023)
DOI: 10.7759/cureus.36597
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Background: The systemic inflammatory response index (SIRI), which depends on peripheral neutrophil, monocyte, and lymphocyte count, was found as an effective prognostic indicator for various malignancies. This study aims to investigate the predictive value of preoperative SIRI in the prognosis of gastric cancer patients without neoadjuvant therapy.

Cite

CITATION STYLE

APA

Yazici, H., & Yegen, S. C. (2023). Is Systemic Inflammatory Response Index (SIRI) a Reliable Tool for Prognosis of Gastric Cancer Patients Without Neoadjuvant Therapy? Cureus. https://doi.org/10.7759/cureus.36597

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free